Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 10Terminated 2Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 884Pancreatic Neoplasms 577Carcinoma, Hepatocellular 543Stomach Neoplasms 516Esophageal Neoplasms 318Rectal Neoplasms 285Colonic Neoplasms 256Breast Neoplasms 206Neoplasms 201Liver Neoplasms 190Lung Neoplasms 175Carcinoma, Non-Small-Cell Lung 174Cholangiocarcinoma 155Ovarian Neoplasms 142Gastrointestinal Neoplasms 135Neoplasm Metastasis 134Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 100Biliary Tract Neoplasms 96Endometrial Neoplasms 84Uterine Cervical Neoplasms 80Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 58Urinary Bladder Neoplasms 54Sarcoma 54Adenocarcinoma Of Esophagus 54Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Interventions

Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Anorexia × Gastrointestinal × Clear all
NCT06989437 2026-05-28

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

Phase 2/3 Recruiting
982 enrolled
Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
66 enrolled
Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡